|
|
Session 11: Enhancing Medicinal Chemistry Productivity and SAR Studies for Better Drugs |
Session Chair: Dr. Zhijian Lu, Department of Basic Chemistry, Merck Research Laboratories, Merck & Co., Inc., USA
Co-Chair: Dr. Ruo Xu, Principle scientist, Schering-Plough Corporation, USA |
|
|
Title: Discovery of Potent and Selective 5-HT1F Receptor Agonists for the Treatment of Acute Migraine
Dr. Deyi Zhang, Principal Research Scientist, Eli Lilly and Company, Indianapolis, USA
|
|
Title: Second Generation Protease Inhibitors against Resistant HIV-1 Viral Variants
Dr. Zhijian Lu, Department of Basic Chemistry, Merck Research Laboratories, Merck & Co., Inc., USA |
|
Title: Yeast Hormone Bioassays: The Only Way to Measure Specific Hormone Activity. A New Yeast Androgen Biosensor, Enabling To Check Findings of QSAR Model Approaches
Dr. Toine F.H. Bovee, Institute of Food Safety, Wageningen University and Research Center, Wageningen, the Netherlands
|
|
Title: Development of Plant Polyphenols as Potential Sensitizers for Cancer Chemotherapy
Dr. Kai Zhang, Dept of Experimental Surgery, Singapore General Hospital, Singapore
|
|
Title: Structure-based Discovery of Novel Antibacterials
Dr. Tom Solmajer, Professor of Medicinal Chemistry National Institute of Chemistry and Lek Pharmaceuticals d.d, Slovenia
|
|
Title: Bicyclic [4.1.0] Heptanes as Phenyl Replacements for Melanin Concentrating Hormone (MCH) Receptor Antagonists
Dr. Ruo Xu, Principle scientist, Schering-Plough Corporation, USA
|
|
Title: White-biocatalysis for Drug Synthesis
Dr. Cristina Silva Pereira, Professor, IBET, Portugal
|
|
